In PC, YTHDC2 was significantly upregulated, positively correlating with Gleason grading and being notably higher in lymph node metastasis castration-resistant prostate cancer (CRPC) compared to CRPC with bone metastasis [74]. This evidence concerns the gene YTHDC2 and metastatic malignant neoplasm in the lymph nodes.